The well-known stop-signal reaction time task, which measures the ability to stop an ongoing response, was administered in a large sample of close to 1,900 14-year old adolescents while lying in the MRI scanner.
First, the WHOQOL-OLD scale was applied in its original version with five response options, and in the second, an adapted version of the scale, following the suggestion by Leão (2012), with three responses was administered.
A questionnaire comprising of fixed and open-ended responses was administered by researchers to participants.
To this end, rats were immunized with either a NIC-KLH immunoconjugate vaccine designed to elicit an antinicotine immune response, or were administered an antinicotine monoclonal antibody, NIC9D9, prior to a series of nicotine challenges and testing sessions.
To evaluate the immune response, mice were administered pathogen free AF (i.n).n
Touch response assays were administered at 48 hpf.
In order to reach uniformity and to avoid an effect on responses, questionnaires were administered in the same order: ESS only at Time A, and PGWBI, followed by SF-12 at Time A and Time B. Diagnosis of OSA was considered disclosed after the physician had informed the patient about the nature of the condition and therapeutic procedures, when appropriate.
Starting 45 days after transplant ("day 45" the second data collection point), three additional open-response items were administered alongside the PARimpact scale items to ascertain the actions that parents took in the previous seven days as a result of their child's BMT.
In response, carbapenem antibiotics were administered for 10 days following the operation, and inflammation was eventually controlled.
However, patients who did not achieve objective clinical response to NAC were administered with four cycles of 5-fluorouracil (600 mg m−2), methotrexate (40 mg m−2), and cyclophosphamide (600 mg m−2) after the surgery.
